Dr. Jacqueline Marie Calkin, MD

Dr. Calkin practices at Golden State Dermatology Associates, Inc. in Sacramento, California.

Dr. Calkin's NPI, 1871561589, was assigned on March 9, 2006. Dr. Calkin graduated from UCSF School of Medicine in 1993. Dr. Calkin holds California license G081375.

Dr. Calkin's primary practice is Golden State Dermatology Associates, Inc., at 2625 Fair Oaks Blvd, Sacramento, CA 95864 in Sacramento County. The practice phone is (925) 932-7704.

Dr. Calkin's primary practice is Golden State Dermatology Associates, Inc. in Sacramento, California. The medical group on file is Golden State Dermatology. Dmand AI also links Dr. Calkin to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Calkin practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Calkin's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Calkin is board certified in dermatology by the American Board of Dermatology. Dr. Calkin is licensed in California.

Dmand AI lists benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, itchy rashes, minor injury to a limb, skin cyst, skin discoloration and yeast infection among the conditions Dr. Calkin treats.

CMS data shows 293 Medicare services from Dr. Calkin across 6 procedure codes in 2024, for 55 Medicare patients. Medicare paid $11,014 for them. Every service was in an office.

CMS counts 55 Medicare patients who saw Dr. Calkin in 2024. The largest group is 65 to 74, with 32 patients. 71% of them have high cholesterol, and 64% have arthritis. Their average risk score is 0.80, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Calkin's median patient age at 58, with 71% women.

In 2024, Dr. Calkin wrote 86 Medicare Part D claims for 39 patients. 95% of them were for generic drugs. CMS names the drug for 43 of them, across 3 drugs with 11 or more claims each, at $1,196 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Calkin for performance year 2024, reported as part of a group. Dr. Calkin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 115 procedures of removal of skin lesions by Dr. Calkin, more than 76% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Calkin in 2022. The most frequent topics are Skin Aging. Dr. Calkin's most frequent co-authors are Alison Ann Boudreaux, MD, Vera A. Chotzen, MD and Suzanne L. Kilmer, MD.

Dmand AI links Dr. Calkin to 1 clinical trial. Conditions studied include Cellulite and Skin Manifestations.

CMS Open Payments shows 760 general payments to Dr. Calkin from 36 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 58% of the total. Galderma Laboratories, L.P. paid the most, $63,997.

Dmand AI lists 3 awards for Dr. Calkin.

Dr. Calkin graduated from UCSF School of Medicine in 1993. Dr. Calkin is a member of AAD and ASDS.

Dr. Calkin is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.